VTCN1 and colorectal carcinoma: In CRC, its relation to B7H4 has not been yet investigated; however, studies show that the level of IL-9 decreased in CRC, along with the progression of the disease, and recent experiments confirmed the antitumour role of IL-9 [39,40,41,42].